Niġerja -
Ingliż -
NAFDAC (National Agency for Food and Drugs Administration and Control)
eloxatin concentrate infusion (pom)
oxaliplatin 5mg/ml
Eġittu -
Ingliż -
EDA (Egyptian Drug Authority)
eloxatin 5mg/ml concentrate for sol.for inf.
sanofi aventis-france - infusion - 5 mg/ml
Eġittu -
Ingliż -
EDA (Egyptian Drug Authority)
eloxatin 5mg/ml concentrate for sol.for inf.
sanofi aventis-france - infusion - 5 mg/ml
Baħrajn -
Ingliż -
الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين
eloxatin concentrate for solution for infusion 5 mg/ml (50mg)
bahrain pharmacy - oxaliplatin - concentrate for solution for infusion - 5
Baħrajn -
Ingliż -
الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين
eloxatin concentrate for solution for infusion 5 mg/ml (100mg)
bahrain pharmacy - oxaliplatin - concentrate for solution for infusion - 5
Baħrajn -
Ingliż -
الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين
eloxatin concentrate for solution for infusion 5 mg/ml (200mg)
bahrain pharmacy - oxaliplatin - concentrate for solution for infusion - 5
Filippini -
Ingliż -
FDA (Food And Drug Administration)
eloxatin 5 mg/ml concentrate for solution for infusion (iv)
n/a; importer: sanofi-aventis philippines, inc.; distributor: n/a - oxaliplatin - concentrate for solution for infusion (iv) - 5 mg/ml
Ingilterra -
Ingliż -
MHRA (Medicines & Healthcare Products Regulatory Agency)
eloxatin 50mg powder for solution for infusion vials
sanofi - oxaliplatin - powder for solution for infusion - 50mg
Ingilterra -
Ingliż -
MHRA (Medicines & Healthcare Products Regulatory Agency)
eloxatin 100mg powder for solution for infusion vials
sanofi - oxaliplatin - powder for solution for infusion - 100mg
Ingilterra -
Ingliż -
MHRA (Medicines & Healthcare Products Regulatory Agency)
eloxatin 50mg/10ml concentrate for solution for infusion vials
sanofi - oxaliplatin - solution for infusion - 5mg/1ml